HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hervé J Brisse Selected Research

Therapeutics

1/2022MRI Characteristics of Pediatric Renal Tumors: A SIOP-RTSG Radiology Panel Delphi Study.
1/2020Exploring heterogeneity of adrenal cortical tumors in children: The French pediatric rare tumor group (Fracture) experience.
1/2020Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience.
4/2013Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
10/2011Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project.
1/2008Imaging in unilateral Wilms tumour.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hervé J Brisse Research Topics

Disease

15Neoplasms (Cancer)
01/2022 - 01/2008
8Retinoblastoma (Glioblastoma, Retinal)
01/2021 - 04/2013
2Wilms Tumor (Wilm's Tumor)
01/2020 - 01/2008
2Sarcoma (Soft Tissue Sarcoma)
01/2020 - 01/2019
2Rhabdomyosarcoma
01/2020 - 07/2017
1Ischemia
01/2021
1Hypotension (Low Blood Pressure)
01/2021
1Residual Neoplasm
01/2020
1Malignant mesenchymal tumor
01/2020
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2020
1Neoplasm Metastasis (Metastasis)
01/2018
1Osteosarcoma (Osteogenic Sarcoma)
01/2018
1Hepatoblastoma
02/2017
1Cicatrix (Scar)
03/2016
1Margins of Excision
04/2013
1Neuroblastoma
10/2011
1Rupture
07/2008

Drug/Important Bio-Agent (IBA)

2Circulating Tumor DNAIBA
01/2021 - 01/2019
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022
1Anaplastic Lymphoma KinaseIBA
01/2022
1Cell-Free Nucleic AcidsIBA
01/2021
1Retinaldehyde (Retinal)IBA
01/2021
1Melphalan (Alkeran)FDA LinkGeneric
01/2021
1Biological ProductsIBA
09/2020
1MicroRNAs (MicroRNA)IBA
12/2019
1penicillamine-glutathione mixed disulfideIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1Etoposide (VP 16)FDA LinkGeneric
01/2018
1Methotrexate (Mexate)FDA LinkGeneric
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1IfosfamideFDA LinkGeneric
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Fetal Proteins (Fetoprotein)IBA
02/2017
1GadoliniumIBA
03/2016
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
04/2013

Therapy/Procedure

6Therapeutics
01/2022 - 01/2008
6Drug Therapy (Chemotherapy)
01/2021 - 09/2015
6Radiotherapy
09/2020 - 01/2008
5Neoadjuvant Therapy
01/2022 - 09/2015
2Aftercare (After-Treatment)
07/2017 - 05/2013
1Treatment Delay
11/2020
1Nephrectomy
01/2019
1Minimally Invasive Surgical Procedures
01/2015
1Consolidation Chemotherapy
04/2013
1Adjuvant Chemotherapy
04/2013